Ticker Details
INmune Bio Inc. Common stock
IPO Date:	February 4, 2019
Sector:	Healthcare
Industry:	Biotechnology
Market Cap:	$64.39M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.36 | 4.30%
Avg Daily Range (30 D):	$0.09 | 4.74%
Avg Daily Range (90 D):	$0.06 | 4.01%

Institutional Daily Volume
Avg Daily Volume:	.32M
Avg Daily Volume (30 D):	.44M
Avg Daily Volume (90 D):	.57M

Trade Size
Avg Trade Size (Sh.):	137
Avg Trade Size (Sh.) (30 D):	143
Avg Trade Size (Sh.) (90 D):	166

Institutional Trades
Total Institutional Trades:	27
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$2.04M
Avg Institutional Trade (90 D):	$2.04M
Avg Institutional Trade Volume:	.17M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.76M
Avg Closing Trade (30 D):	$2.04M
Avg Closing Trade (90 D):	$2.04M
Avg Closing Volume:	281.68K

News

Jun 2, 2026 @ 12:00 PM INmune Bio Reports Statistically Significant Treat... Source: Inmune Bio Inc.

May 15, 2026 @ 12:00 PM INmune Bio Publishes Phase 2 MINDFuL Trial Results... Source: Na

May 14, 2026 @ 12:00 PM INmune Bio Receives FDA Fast Track Designation for... Source: Inmune Bio Inc.

May 7, 2026 @ 8:00 PM INmune Bio Inc. Announces First Quarter 2026 Resul... Source: Inmune Bio Inc.

Apr 30, 2026 @ 12:00 PM INmune Bio Inc. to Report First Quarter 2026 Finan... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.67	$-.05	$-.2
Diluted EPS	$-.67	$-.05	$-.2
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-18.42M	$-1.27M	$-5.41M
Operating Income / Loss	$-20.2M	$-1.48M	$-5.81M
Cost of Revenue
Net Cash Flow	$-18.63M	$-2.95M	$-3.39M
PE Ratio